Predictive Role of Neutrophils and Clinical Features Associated with Long-Term Ruxolitinib Exposure in Myelofibrosis
Latest Information Update: 31 Jan 2022
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Myelofibrosis
- Focus Therapeutic Use
Most Recent Events
- 31 Jan 2022 New trial record
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition